The Short and Long-term Cardiovascular Consequences of Critical Illness: The C3 Study

NCT ID: NCT04545437

Last Updated: 2023-04-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

80000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-08-10

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim this study will be to find out which patients are at risk of heart attacks/strokes up to several years after discharge from an ICU. This study will also investigate whether treatments and events occurring in ICU contribute to this risk.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Undertake a retrospective observational cohort study of patients admitted to intensive care units between 2006 and 2023.

Study Participants: Adult patients admitted to a general adult intensive care unit at one or more of the study sites between 2006 and 1st of August 2023.

Objectives:

To determine the short and long-term cardiovascular consequences of critical illness and identify in-ICU factors that affect them.

To identify the risk factors for new-onset atrial fibrillation/flutter occurring during critical illness.

To study the association between poor cardiovascular function during critical illness and long-term cardiovascular disease.

This study will provide new knowledge about the associations between baseline cardiovascular risk, the disease resulting in ICU admission and therapies / events on ICU with subsequent major adverse cardiac events (MACE), to allow the ongoing risk of these events to be determined. If clinicans can idetnify who is at risk, then risk factors can potentially be modified .

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critical Illness Myocardial Infarction Stroke Atrium; Fibrillation Atrial Flutter

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ICU

Patients treated on a general adult intensive care unit

Admission to ICU

Intervention Type OTHER

Exposure is admission to an Intensive Care Unit

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Admission to ICU

Exposure is admission to an Intensive Care Unit

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 16 years or above.
* Admitted to an intensive care unit at a study site from 2006 onwards

Exclusion Criteria

* Patients that have informed their participating site that they do not wish their electronic records would be used for future research
* Patients who inform us directly that they don't wish their records used in this research study
Minimum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Oxford

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Peter Watkinson

Role: STUDY_DIRECTOR

University of Oxford

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Royal Berkshire NHS Foundation Trust

Reading, Berkshire, United Kingdom

Site Status RECRUITING

Oxford University Hospitals

Oxford, Oxfordshire, United Kingdom

Site Status RECRUITING

Imperial College Healthcare NHS Trust

London, , United Kingdom

Site Status SUSPENDED

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Robert Hatch

Role: CONTACT

+44 (0) 1865 231456

Jonathan Bedford

Role: CONTACT

+44 (0) 1865 231456

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ian Rechner

Role: primary

Peter Watkinson

Role: primary

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Oxford Rec C

Identifier Type: OTHER

Identifier Source: secondary_id

Confidentiality Advisory Group

Identifier Type: OTHER

Identifier Source: secondary_id

PID14762

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Frailty in Critical Care Unit's Patients
NCT06117462 NOT_YET_RECRUITING
The ICU Care Knowledge Study
NCT00305981 COMPLETED